Encompass Health officer uses shares for tax withholding

Encompass Health Corp Chief Accounting Officer Andrew L. Price disposed of 404 shares of Encompass Health common stock on a tax-withholding basis.

Accepted by SEC EDGAR 02/25/2026 - 09:17 AM EST Learn about SEC filing dates

Rhea-AI Filing Summary

Encompass Health Corp Chief Accounting Officer Andrew L. Price disposed of 404 shares of Encompass Health common stock on a tax-withholding basis. The shares, valued at $106.15 each, were withheld to cover taxes due upon vesting of related restricted stock. After this transaction, Price held 75,001 shares directly.

Insider Trade Summary

Exercise Price or Tax Liability: 404 shares

Exercise Price or Tax Liability 1 txn

Insider Price Andrew L

Role Chief Accounting Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Encompass Health Common Stock	404	$106.15	$43K

Holdings After Transaction: Encompass Health Common Stock — 75,001 shares (Direct)

Holdings Before and After: Encompass Health Common Stock, 75,405 to 75,001 shares (Direct)

Footnotes (1)

1. F1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Encompass Health (EHC) officer Andrew L. Price report on this Form 4?

Andrew L. Price reported a tax-withholding disposition of 404 Encompass Health shares. These shares were withheld to satisfy tax obligations from vesting restricted stock, and he continued to own 75,001 shares directly afterward.

Was the Encompass Health (EHC) Form 4 transaction an open-market sale?

No, the transaction was a tax-withholding disposition, not an open-market sale. Shares were surrendered to cover tax liabilities from vesting restricted stock, as described in the filing footnote.

How many Encompass Health (EHC) shares were disposed of in this insider filing?

The Form 4 shows a disposition of 404 shares of Encompass Health common stock. The shares were valued at $106.15 each and were withheld to pay the insider’s tax withholding obligations on vesting restricted stock.

How many Encompass Health (EHC) shares does Andrew L. Price hold after the transaction?

After the tax-withholding transaction, Andrew L. Price directly owned 75,001 Encompass Health shares. This figure reflects his remaining holdings following the 404 shares surrendered for tax obligations tied to restricted stock vesting.

What does transaction code F mean in the Encompass Health (EHC) Form 4?

Transaction code F indicates shares used to pay an exercise price or tax liability. In this case, shares were withheld to satisfy the insider’s tax withholding obligations arising from vesting restricted stock, rather than an ordinary market trade.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Price Andrew L

(Last) (First) (Middle)

9001 LIBERTY PARKWAY

(Street)

BIRMINGHAM AL 35242

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Encompass Health Corp [ EHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Accounting Officer

3. Date of Earliest Transaction (Month/Day/Year)
02/23/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Encompass Health Common Stock	02/23/2026		F		404(1)	D	$106.15	75,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were withheld or surrendered to pay the insider's tax withholding obligations incurred in connection with the vesting of the related restricted stock.

	/s/ Patrick Darby, attorney-in-fact for Mr. Price	02/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.